Abiopharma

News list

Laing Lance G. 🟢 acquired 30.0K shares (1 derivative) of Celcuity Inc. (CELC) Transaction Date: Aug 14, 2026 | Filing ID: 000004

Full text

News bot Aug. 18, 2026, 8:53 p.m.
🔍 Laing Lance G. (Executive)

Company: Celcuity Inc. (CELC)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 30,000
Detailed Transactions and Holdings:
- Acquired 20,000 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,271,000.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 10,000 shares of Performance Stock Units (Derivative)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
Footnotes:
- F1: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date.
- F2: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.